Epstein-barr virus and the somatic hypermutation of immunoglobulin genes in burkitt's lymphoma cells

Journal of Virology

Volumn 75, Issue 21, 2001, Pages 10488-10492

  Harris, R S ^a   Croom Carter, D S G ^a   Rickinson, A B ^a   Neuberger, M S ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; VIRUS PROTEIN;

ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENE; VIRUS LATENCY;

AMINO ACID SEQUENCE; BASE SEQUENCE; BURKITT LYMPHOMA; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENES, IMMUNOGLOBULIN; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN M; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, ANTIGEN, B-CELL; TUMOR CELLS, CULTURED; VIRAL MATRIX PROTEINS;

EID: 0034790445     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.21.10488-10492.2001     Document Type: Article

References (27)

1. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein
2. The expression pattern of Epstein-Bart virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell
3. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors
4. T cells can induce somatic mutation in B cell receptor-engaged BL2 Burkitt's lymphoma cells independently of CD40-CD40 ligand interactions
5. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines
6. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): Immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease
7. Cells expressing the Epstein-Barr Virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils
8. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection
9. Expression of the Epstein-Bart virus latent membrane protein 1 induces B cell lymphoma in transgenic mice
10. EBV-infected B cells in infectious mononucleosis. Viral strategies for spreading in the B cell compartment and establishing latency
11. Phenotypes of Epstein-Bart virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells
12. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue
13. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: A role for the WIW2 repeat domain
14. Epstein-Bart virus
15. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: Comparative sensitivity to non-specific and to alto-specific cytotoxic responses in vitro
16. Monoclonal antibodies to the latent membrane protein of Epstein-Bart virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells
17. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells
18. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins
19. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line
20. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells
21. EBNA-2 and EBNA-LP cooperate to cause GO to G1 transition during immortalization of resting human B lymphocytes by Epstein-Bart virus
22. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses
23. Epstein-Barr virus (EBV) recombinants: Use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells
24. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants
25. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
26. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease
27. Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus